Login to Your Account

Academics propose path to undercut sky-high cancer drug costs

By Michael Fitzhugh
Staff Writer

Thursday, February 9, 2017

Leaders at four academic drug centers have proposed that colleagues battle high cancer drug prices by resisting the temptation to sell promising candidates to the highest bidder.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription